This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cuevas, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuevas, O.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2004, p. 4240-4245, Vol. 48, No. 11
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.11.4240-4245.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Evolution of the Antimicrobial Resistance of Staphylococcus spp. in Spain: Five Nationwide Prevalence Studies, 1986 to 2002

Oscar Cuevas, Emilia Cercenado,* Ana Vindel, Jesús Guinea, Matilde Sánchez-Conde, Mar Sánchez-Somolinos, Emilio Bouza, and the Spanish Group for the Study of Staphylococcus{dagger}

Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario "Gregorio Marañón," Madrid, Spain

Received 19 February 2004/ Returned for modification 28 May 2004/ Accepted 26 July 2004

Data regarding the evolution of Staphylococcus resistance in a whole country have a definite influence on the design of empirical treatment regimens. Nevertheless, incidence studies over long periods of time are expensive and very difficult to carry out. In order to ascertain the present situation of the antimicrobial resistance of Staphylococcus in Spain and the change of this resistance over time, we performed five point prevalence studies (1986 to 2002) in a large group of Spanish hospitals (from 68 institutions in 1986 to 143 in 2002) collecting all Staphylococcus strains isolated on a single selected day. All microorganisms were identified in the five studies at the same laboratory, and antimicrobial susceptibility testing was performed against 17 antimicrobial agents by the agar dilution method and a microdilution method. During this period, there was an overall increase in resistance to most antimicrobials among Staphylococcus aureus/coagulase-negative staphylococci, mainly to oxacillin (1.5%/32.5% in 1986 versus 31.2%/61.3% in 2002) (P < 0.001), erythromycin (7%/41.1% in 1986 versus 31.7%/63% in 2002) (P < 0.001), gentamicin (5.2%/25.4% in 1986 versus 16.9%/27.8% in 2002) (P < 0.001; P = 0.5), and ciprofloxacin (0.6%/1.1% in 1986 versus 33.9%/44.9% in 2002) (P < 0.001). All of the isolates were uniformly susceptible to glycopeptides, linezolid, and quinupristin/dalfopristin. Resistance of S. aureus to trimethoprim/sulfamethoxazole was very low (from 0.5% to 2.1%) (P = 0.152). Periodic performance of prevalence studies is a useful, inexpensive, and easy tool to know the nationwide situation of a microorganism and its resistance to antimicrobials; it also helps us assess the emergence and spread of antimicrobial resistance.


* Corresponding author. Mailing address: Servicio de Microbiología Clínica y E. Infecciosas, Hospital General Universitario "Gregorio Marañón," Dr. Esquerdo 46, 28007 Madrid, Spain. Phone: 34-91-586-8459. Fax: 34-91-504-4906. E-mail: ecercenado{at}teleline.es.

{dagger} Contributing members of the Spanish Group for the Study of Staphylococcus are listed in Acknowledgments.


Antimicrobial Agents and Chemotherapy, November 2004, p. 4240-4245, Vol. 48, No. 11
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.11.4240-4245.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Vindel, A., Cuevas, O., Cercenado, E., Marcos, C., Bautista, V., Castellares, C., Trincado, P., Boquete, T., Perez-Vazquez, M., Marin, M., Bouza, E., and the Spanish Group for the Study of Staphylococ, (2009). Methicillin-Resistant Staphylococcus aureus in Spain: Molecular Epidemiology and Utility of Different Typing Methods. J. Clin. Microbiol. 47: 1620-1627 [Abstract] [Full Text]  
  • Perez-Vazquez, M., Vindel, A., Marcos, C., Oteo, J., Cuevas, O., Trincado, P., Bautista, V., Grundmann, H., Campos, J., on behalf of the EARSS Spain spa-typing Group, (2009). Spread of invasive Spanish Staphylococcus aureus spa-type t067 associated with a high prevalence of the aminoglycoside-modifying enzyme gene ant(4')-Ia and the efflux pump genes msrA/msrB. J Antimicrob Chemother 63: 21-31 [Abstract] [Full Text]  
  • Torres, E., Perez, S., Villanueva, R., Bou, G. (2008). Evaluation of the Vitek 2 AST-P559 Card for Detection of Oxacillin Resistance in Staphylococcus aureus. J. Clin. Microbiol. 46: 4114-4115 [Full Text]  
  • Jamaluddin, T. Z. M. T., Kuwahara-Arai, K., Hisata, K., Terasawa, M., Cui, L., Baba, T., Sotozono, C., Kinoshita, S., Ito, T., Hiramatsu, K. (2008). Extreme Genetic Diversity of Methicillin-Resistant Staphylococcus epidermidis Strains Disseminated among Healthy Japanese Children. J. Clin. Microbiol. 46: 3778-3783 [Abstract] [Full Text]  
  • Bailey, J., Summers, K. M. (2008). Dalbavancin: A new lipoglycopeptide antibiotic. Am J Health Syst Pharm 65: 599-610 [Abstract] [Full Text]  
  • Steinkraus, G., White, R., Friedrich, L. (2007). Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05. J Antimicrob Chemother 60: 788-794 [Abstract] [Full Text]  
  • Vindel, A., Trincado, P., Gomez, E., Cabrera, R., Boquete, T., Sola, C., Valdezate, S., Saez-Nieto, J. A. (2006). Prevalence and Evolution of Methicillin-Resistant Staphylococcus aureus in Spanish Hospitals between 1996 and 2002. J. Clin. Microbiol. 44: 266-270 [Abstract] [Full Text]  
  • Weese, J. S. (2005). Methicillin-Resistant Staphylococcus aureus: An Emerging Pathogen in Small Animals. Journal of the American Animal Hospital Association 41: 150-157 [Abstract] [Full Text]